elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38613173-F9294FD8-6E80-4417-AFE0-FE4D666B38F5
Q38613173-F9294FD8-6E80-4417-AFE0-FE4D666B38F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38613173-F9294FD8-6E80-4417-AFE0-FE4D666B38F5
FRAX and fracture prediction without bone mineral density.
P2860
Q38613173-F9294FD8-6E80-4417-AFE0-FE4D666B38F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38613173-F9294FD8-6E80-4417-AFE0-FE4D666B38F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f352957218225b8ee850b36562463527fef27c48
P2860
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.